Skip to main content
SpringerLink
Log in

Impact of Ultrasonic Vibrations on the Stability of Bovhyaluronidase Azoximer in Solution

  • STRUCTURE OF CHEMICAL COMPOUNDS, METHODS OF ANALYSIS AND PROCESS CONTROL
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Changes in the quantitative content and specific activity of hyaluronidase enzyme after ultrasonic treatment of solutions of bovhyaluronidase azoximer were studied. Solutions of the finished dosage form of bovhyaluronidase azoximer (Longidase® lyophilizate for preparation of solution for injection, 3000 IE) and bovhyaluronidase azoximer drug substance (Longidase® substance-lyophilizate) were studied. The aim of the study was to determine the effect of ultrasound (US) on the stability of bovhyaluronidase azoximer determined from the measured quantitative content and enzymatic activity of the substance in solution. US at a radiation intensity of 61.4 W/L during treatment in an ultrasonic bath did not significantly affect the quantitative content of the bovhyaluronidase azoximer drug substance in solution, while the decrease in the enzymatic activity of the active substance in Longidase solution after 20 and 30 min of ultrasonic treatment was statistically significant. At the same time, the enzymatic activity of the active substance determined by a biochemical method differed significantly (residual activity from 99.70% to 59.27%) depending on the design features of the nebulizers and the nebulization time after nebulization of the bovhyaluronidase azoximer solution in mesh nebulizers from various manufacturers. Nebulization times of min were least associated with the risk of significant loss of stability of bovhyaluronidase azoximer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. D. V. Bates, B. R. Fish, T. F. Hatch, et al., Health Phys., 12(2), 173 – 207 (1966).

    CAS  PubMed  Google Scholar 

  2. R. Dhand, Respir. Care, 47(12), 1406 – 1416 (2002).

    PubMed  Google Scholar 

  3. S. N. Avdeev, Russ. Med. Zh., No. 19, 945 – 952 (2013).

  4. A. A. Zaitsev, M. A. Kharitonov, V. A. Chernetsov, et al., Med. Sovet, No. 15, 102 – 106 (2019).

  5. L. Vecellio, Breathe, 2(3), 252 – 260 (2006).

    Article  Google Scholar 

  6. M. A. Kutsenko and A. G. Chuchalin, Russ. Med. Zh., No. 29, 1440 – 1445 (2013).

  7. Yu. S. Butov and V. Yu. Vasenova, Eff. Farmakoter. Dermatovenerol. Dermatokosmetol., 11(2), 40 – 43 (2012).

    Google Scholar 

  8. A. M. Dygai, O. V. Pershina, V. A. Krupin, et al., Sib. Nauchn. Med. Zh., No. 4, 5 – 10 (2017).

  9. V. A. Zaitsev, L. A. Khodyreva, A. A. Dudareva, et al., Klin. Dermatol. Venerol., 15(3), 53 – 60 (2016).

    Article  Google Scholar 

  10. Y. Shi, Y. Wang, C. Shao, et al., Cell Death Diff., 27(5), 1451 – 1454 (2020).

    Article  CAS  Google Scholar 

  11. Z. Xu, L. Shi, Y. Wang, et al., Lancet Respir Med., 8(4), 420 – 422 (2020).

    CAS  Google Scholar 

  12. R. Hallgren, T. Samuelsson, T. Laurent, et al., Am. Rev. Respir. Dis., 139(3), 682 – 687 (1989).

    Article  CAS  PubMed  Google Scholar 

  13. A. G. Chuchalin, P. K. Yablonskii, T. V. Rubanik, et al., Pul’monologiya, 33(1), 52 – 63 (2023).

    Article  Google Scholar 

  14. E. R. Lapinskaya, A. N. Mironov, and M. A. Khenok, Dokl. Akad. Nauk SSSR, 95(1), 109 – 117 (1954).

    Google Scholar 

  15. R. A. Khromova, Author’s Abstract of a Candidate Dissertation in Technical Sciences, Moscow (1971).

  16. A. G. Chuchalin, N. L. Knyazheskaya, and M. O. Potapova, Russ. Med. Zh., 14(7), 521 – 526 (2006).

    Google Scholar 

  17. O. V. Zairat’yants, A. G. Malyavin, M. V. Samsonova, et al., Terapiya, No. 5, 35 – 46 (2020).

  18. V. S. Nikonova, Trudnyi Patsient, No. 6, 10 – 14 (2013).

    Google Scholar 

  19. O. A. Chernyavskaya and A. V. Osipov, Med. Sovet, No. 12, 154 – 160 (2021).

Download references

Author information

Authors and Affiliations

  1. Pirogov Russian National Research Medical University, Ministry of Health of Russia, 1 Ostrovityanova St., Moscow, 117997, Russia

    A. E. Krasheninnikov, V. V. Sepp, K. S. Bakulin, O. I. Arefieva & A. A. Karsanov

Authors
  1. A. E. Krasheninnikov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. V. Sepp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. S. Bakulin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. I. Arefieva
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. A. Karsanov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. V. Sepp.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 58, No. 1, pp. 56 – 60, January, 2024.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Krasheninnikov, A.E., Sepp, V.V., Bakulin, K.S. et al. Impact of Ultrasonic Vibrations on the Stability of Bovhyaluronidase Azoximer in Solution. Pharm Chem J (2024). https://doi.org/10.1007/s11094-024-03127-9

Download citation

  • Received:

  • Published:

  • DOI: https://doi.org/10.1007/s11094-024-03127-9

Keywords

Search

Navigation